Segment Information (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Financial Information by Segment

The following tables present financial information by segment:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Net revenue:
Products & Healthcare Services	$	2,010,605	$	1,930,723	$	3,985,442	$	3,846,212
Patient Direct		660,401		632,503		1,298,244		1,239,863
Consolidated net revenue	$	2,671,006	$	2,563,226	$	5,283,686	$	5,086,075
Operating income:
Products & Healthcare Services	$	11,468	$	2,940	$	22,954	$	4,761
Patient Direct		64,787		59,065		110,666		104,914
Acquisition-related charges and intangible amortization		(19,985)		(22,203)		(40,298)		(44,392)
Exit and realignment charges, net		(29,293)		(28,963)		(56,649)		(44,637)
Litigation and related charges(1)		(6,678)		—		(6,678)		—
Consolidated operating income	$	20,299	$	10,839	$	29,995	$	20,646
Depreciation and amortization:
Products & Healthcare Services	$	19,084	$	18,772	$	42,450	$	37,338
Patient Direct		44,795		53,290		95,524		105,650
Consolidated depreciation and amortization	$	63,879	$	72,062	$	137,974	$	142,988
Share-based compensation:
Products & Healthcare Services	$	4,786	$	3,234	$	9,555	$	7,732
Patient Direct		1,526		1,562		2,933		3,414
Other(2)		423		416		1,113		529
Consolidated share-based compensation	$	6,735	$	5,212	$	13,601	$	11,675
Capital expenditures:
Products & Healthcare Services	$	3,117	$	6,602	$	11,367	$	12,934
Patient Direct		42,683		42,887		83,841		88,045
Consolidated capital expenditures	$	45,800	$	49,489	$	95,208	$	100,979

⁽¹⁾ Litigation and related charges includes settlement costs and related fees of legal matters within our Apria division, which do not occur in the ordinary course of our business, are non-recurring/infrequent and are inherently unpredictable in timing and amount. These charges are reported within Other operating expense, net in our Statements of Operations for the three and six months ended June 30, 2024.

⁽²⁾ Other share-based compensation expense is captured within Exit and realignment charges, net or Acquisition-related charges for the three and six months ended June 30, 2024 and 2023.

Consolidated Total Assets

	June 30, 2024		December 31, 2023
Total assets:
Products & Healthcare Services	$	2,524,240	$	2,359,825
Patient Direct		2,536,093		2,490,460
Segment assets		5,060,333		4,850,285
Cash and cash equivalents		243,671		243,037
Consolidated total assets	$	5,304,004	$	5,093,322

Financial Information by Geographic Area

The following table presents net revenue by geographic area, which were attributed based on the location from which we ship products or provide services:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Net revenue:
United States	$	2,609,010	$	2,498,536	$	5,159,620	$	4,951,472
International		61,996		64,690		124,066		134,603
Consolidated net revenue	$	2,671,006	$	2,563,226	$	5,283,686	$	5,086,075